WHO recommends two new drugs to treat patients with COVID-19

The drug baricitinib (a type of drug known as a Janus kinase (JAK) inhibitor, also used to treat rheumatoid arthritis) is strongly recommended for patients with severe or critical COVID-19 in combination with corticosteroids, says a WHO Guideline Development Group of international experts in The BMJ today.

This article was originally published on MedicalXpress.com

Read More: